EVM14 is the first messenger RNA (mRNA) therapeutic vaccine developed internally by the company to gain this approval. Its ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.

The research field of 'cellular IRESes' lay dormant for decades, as there was no uniform standard of reliable methods for the clear characterization of these starting points for the ribosome-mediated ...

In the early 1990s, Katalin Karikó was obsessed with an idea most of her fellow scientists dismissed: Could messenger RNA, or ...

Only recently has the ribosome—one of the oldest molecular machines in evolutionary terms—been recognized as an active ...

Federal funding for biomedical research pays off by enabling basic discoveries that lead to lifesaving treatments, writes ...

Only recently has the ribosome - one of the oldest molecular machines in evolutionary terms - been recognized as an active regulator of gene expression at the level of protein biosynthesis.

Genes have to be expressed in the right place, at the time, and at the right levels. Scientists wanted to know more about how ...

The results of this work reveal how an alternative splicing mechanism regulates an essential factor for neuronal identity.

Radiation therapy is a powerful tool for fighting cancer, but it comes with painful side effects. About 60% of cancer ...